Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
KEY PRODUCTS
KEY SERVICES
Reset all filters
01 1Cohance Lifesciences
Reset all filters
01 1DESVENLAFAXINE SUCCINATE
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40846
Submission : 2024-11-20
Status : Active
Type : II
20
Cohance Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
One of their notable products is DESVENLAFAXINE SUCCINATE, with a corresponding US DMF Number 40846.
Remarkably, this DMF maintains an Active status since its submission on November 20, 2024, highlighting commitment to regulatory compliance.